BOTOX® Cosmetic Archives - Page 2 of 2

9

Aug

XEOMIN is the Newest Botulinum Toxin to Receive FDA Approval

Published: August 9, 2010

A third botulinum toxin type A product has been approved by the FDA. XEOMIN, a product of Merz Pharmaceuticals, earned approval last week for the treatment of adults with cervical dystonia or blepharospasm. The FDA approval of XEOMIN is based on the results of two U.S. clinical trials. It joins Botox and Dysport as botulinum … Continue reading XEOMIN is the Newest Botulinum Toxin to Receive FDA Approval →

2

Aug

Could No-needle Botox be a Few Years Away?

Published: August 2, 2010

A bio-pharmaceutical company in California is exploring a “no-needle” Botox product that could be applied to the skin in cream form like a lotion, reports WCBS-TV in New York City. Revance Therapeutics says that it will be two years before clinical trials of the product—called RT001—are complete. Then it will be up to the FDA … Continue reading Could No-needle Botox be a Few Years Away? →

14

Jul

Botox Approved as Migraine Treatment in U.K.

Published: July 14, 2010

Well known as a wrinkle fighter, Botox has now been approved by the U.K.’s drug regulators to treat chronic migraines. Allergan, the maker of Botox, announced last week that it can now be used on migraine patients in the U.K. who have headaches at least 15 days a month, including migraines on 8 days. The … Continue reading Botox Approved as Migraine Treatment in U.K. →

17

Jun

Study Examines Botox’s Effect on Emotions

Published: June 17, 2010

A new study published in the journal Emotion examines whether Botox injections have an effect on the patient’s emotional experience. Joshua Davis and Ann Senghas, Barnard College professors who led the research, wanted to see if feedback from facial expressions influences emotional experience. They compared the self-reported emotional experiences of those with Botox injections (which … Continue reading Study Examines Botox’s Effect on Emotions →

Blog

Categories

BOTOX® Cosmetic

XEOMIN is the Newest Botulinum Toxin to Receive FDA Approval

Could No-needle Botox be a Few Years Away?

Botox Approved as Migraine Treatment in U.K.

Study Examines Botox’s Effect on Emotions

Schedule Consultation